Attached files
| file | filename |
|---|---|
| EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - VIVOS INC | ex31-1.htm |
| EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - VIVOS INC | ex31-2.htm |
| 10-K - FORM 10-K - VIVOS INC | advmed10k_dec312016.htm |
EXHIBIT 32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the accompanying annual report of Advanced Medical
Isotope Corporation (the “Company”) on Form 10-K for
the year ended December 31, 2016 (the
“Report”), the undersigned, Michael K. Korenko, Chief
Executive Officer of the Company, and L. Bruce Jolliff, Chief
Financial Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:
(1) The
Report fully complies with the requirements of section 13(a) or
15(d), as applicable, of the Securities Exchange Act of 1934, as
amended; and
(2) The
information contained in the Report fairly presents, in all
material respects, the financial condition and results of
operations of the Company.
Date:
March 8, 2016
/s/ Michael K. Korenko
Name:
Michael K.
Korenko
Title:
Chief
Executive Officer
/s/ L. Bruce Jolliff
Name:
L.
Bruce Jolliff
Title:
Chief
Financial Officer